A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
Latest Information Update: 06 Dec 2019
At a glance
- Drugs Vandetanib (Primary)
- Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma; Gliosarcoma; Oligodendroglioma
- Focus Adverse reactions
- 18 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov (NCT00293566).
- 18 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov (NCT00293566).
- 07 Aug 2006 New trial record.